Kasan Insight :: Korea IP Law Blog

Korea IP Law and Practice on Patent, Design, Trademark, Copyright, Trade Secrets and Unfair Competition

Trade Secret Protection in South Korea

1. What is Trade Secret under Korean law? “Trade secret” under Article 2.2 of the UCPA of Korea means technical or business informa...

Statistics of KIPO - IP Applications Trend Over Three Years in Korea

Statistics of KIPO - IP Applications Trend Over Three Years in Korea

12 Months Grace Period in Korea

Article 30 of the Korean Patent Act provides 12 months grace period for disclosed inventions. In inventor or his assignee may obtain a pate...

BMS sued Korean pharmaceutical companies alleging patent infringement of entecavir compound patent and low dose formulation patent

Baraclude tablets are a blockbuster drug of BMS that has been sold for the treatment of chronic hepatitis B virus infection in Korea. BMS ...

IPT Decided One of 2 Patents on Herceptin (trastuzumab) Listed in Green List of KFDA as being Invalid

Roche launched Herceptin for the treatment of HER2-positive metastatic breast cancer in Korea. And Celltrion, a Korean Pharmaceutical compa...

View web version

Powered by Blogger.